INTRODUCTION AND OBJECTIVES: Cavernosal apoptosis and fibrosis are important pathophysiologies of post-radical prostatectomy erectile dysfunction (ED). Recent studies showed that JNK inhibition alone or LIMK2 inhibition alone improved ED by suppressing cavernosal apoptosis or fibrosis, respectively. Thus, this study aimed to determine if combined administration of LIM-kinase 2 (LIMK2) and Jun-amino terminal kinase (JNK) inhibitors in a rat model of ED induced by cavernosal nerve (CN) injury could restore erectile function by suppressing both apoptosis and fibrosis of corpus cavernosum via rectification of molecular pathways related to the structural alterations.
INTRODUCTION AND OBJECTIVES: Cavernosal apoptosis and fibrosis are important pathophysiologies of post-radical prostatectomy erectile dysfunction (ED). Recent studies showed that JNK inhibition alone or LIMK2 inhibition alone improved ED by suppressing cavernosal apoptosis or fibrosis, respectively. Thus, this study aimed to determine if combined administration of LIM-kinase 2 (LIMK2) and Jun-amino terminal kinase (JNK) inhibitors in a rat model of ED induced by cavernosal nerve (CN) injury could restore erectile function by suppressing both apoptosis and fibrosis of corpus cavernosum via rectification of molecular pathways related to the structural alterations.
METHODS: Sixty 12-week-old male Sprague-Dawley rats were equally categorized into four groups: (i) Sham surgery (Sham) group, (ii) CN crush injury (CNCI), (iii) CNCI group (CNCIþLþLJ) treated with a combination of 10.0 mg/kg LIMK2 inhibitors and low-dose (1.0 mg/kg) JNK inhibitors, and (iv) CNCI group (CNCIþLþHJ) treated with a combination of 10 mg/kg LIMK2 inhibitors and a high dose (10.0 mg/kg) of JNK inhibitors. Ten days after surgery, erectile response using electrostimulation, histological studies, and Western blot was investigated.
RESULTS: The CNCI group showed a significant reduction of maximal ICP/MAP or AUC/MAP, decreased immunohistochemical staining of AE-smooth muscle actin (SMA), decreased SM/collagen ratio, increased number of apoptotic cells positive for phospho-cJun, increased number of fibroblasts positive for phospho-LIMK2, increased cJun phosphorylation, increased LIMK2 or Cofilin phosphorylation, decreased Bcl-2/Bax ratio, and increased protein expression of fibronectin, compared to the Sham group. Both the CNCIþLþLJ and CNCIþLþHJ groups showed improvements in erectile responses, the content of cavernosal AE-SMA, the number of apoptotic cells positive for phospho-cJun, Bcl-2/Bax ratio and cJun phosphorylation in a dose-dependent manner of a JNK inhibitor, together with rectification of SM/collagen ratio, the number of fibroblasts positive for phospho-LIMK2, LIMK2/Cofilin phosphorylation, and protein expression of fibronectin.
CONCLUSIONS: This study suggests that combined inhibition of JNK and LIMK2 may improve erectile function by suppression of cavernosal apoptosis and fibrosis via restoration of cJun/Bcl-2/Bax and LIMK2/Cofilin pathways at the acute phase after CN injury. Thus, the combined inhibition may be a potential mechanism-specific targeted therapy for ED induced by CN injury.
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MP59-10 ADIPOSE-DERIVED STEM CELLS (ASCS) COMBINED WITH CONTROL-RELEASED DF-PEG/GCS HYDROGEL SCAFFOLD RESTORE THE ERECTILE FUNCTION IN A DIABETES RAT MODEL
Hao Yan*, Dong Dong Xiao, Mujun Lu, Shanghai, China, People's Republic of INTRODUCTION AND OBJECTIVES: To investigate the feasibility of seeding adipose-derived stem cells (ASCs) onto a controlreleased hydrogel scaffold, Telechelic difunctional poly/ Glycol chitosan (DF-PEG/GCS), and then inject the scaffold into corpus cavernosum for erectile function restoration in a diabetes mellitus erectile dysfunction rat model and investigate the underlying mechanism.
METHODS: DF-PEG/GCS Hydrogel scaffold were evaluated with scanned electron microscope (SEM) and assessed its biocompatibility in vivo. Fourty-eight 8-week-old male Sprague-Dawley rats were randomly divided into 6 groups, including the Normal (n [ 8) group, PBS (n [ 8) group, ASCs (n [ 8) group, GþASCs group (n [ 8), DþASCs group (n [ 8) and HþASCs group (n [ 8). For in vivo studies, rats with streptozocin-induced DM were intravenously injected with PBS, ASCs or ASCs seeded on GCS, DF-PEG or DF-PEG/GCS Hydrogel and rats in Normal group were injected with an equal volume of vehicle solution. Twelve weeks later, the intracavernosal pressure (ICP) and mean arterial pressure (MAP) were measured to assess erectile function, and penile tissues were harvested for further evaluation.
RESULTS: A significant fall in the ICP was obvious in diabetic rats compared with normal rats. After rats with diabetes were treated with ASCs seeded DF-PEG/GCS Hydrogel, the ICP/MAP ratio significantly increased compared with that in the PBS group. Partial restoration of the ICP was observed in ASCs group. The CD31, a-SMA and NEUN expression levels were considerably decreased in the corpus cavernosum tissue of the PBS group compared with the Normal group (P < 0.05;). Twelve weeks after treatment with ASCs, expression levels of CD31, NEUN and a-SMA were significantly increased compared with those treated with PBS (P < 0.05). Densitometric analysis of the band intensity revealed that in all cases, the decrease in expression of cell growth factors (NGF, BDNF and VEGF) as a result of diabetes in the rats was partially recovered by ASCs, and further restored by ASCs seeded DF-PEG/GCS hydrogel scaffold.
CONCLUSIONS: These results demonstrate that adiposederived stem cells (ASCs) seeded on a control-released DF-PEG/ GCS Hydrogel scaffold could significantly restore the erectile function in a DMED model. ASCs promoted the corpus smooth muscle regeneration and vascularization by inhibiting apoptosis and secreting bioactive factors thus promoting the recovery of erectile function in diabetic rats, and these effects could be enhanced by DF-PEG/GCS Hydrogel. In the present study, we explored the miRs profile in the corpus cavernosum (CC) of diabetic rats with erectile dysfunction (ED) and investigated the role of selected miR in regulating the contraction of CC smooth muscle (CCSM) in diabetic ED rats.
Source of
METHODS: Agilent Rat miRNA V18.0 microarray was used to determine the expression profile of miRs in diabetic ED rats. After comparative analysis, 3 miRs appeared distinctly expressed in diabetic ED group (fold change ! 3), and the aberrantly expressed miRs were further confirmed by qPCR. Among them, the expression of "myomiR", miR-133b, was identified as a candidate for CCSM contraction processes. CCSM cells were cultured in high glucose conditions as a diabetic model. Streptozotocin-induced Sprague-Dawley rats were set up, and an apomprphine test was conducted to confirm diabetic ED. The role of miR-133b in regulating CCSM was then explored by upand downregulation its expression in vitro and in vivo.
RESULTS: The protein expressions of p-MYPT1 and p-CPI-17 were increased while expression of miR-133b was decreased in diabetic condition. A luciferase reporter assay confirmed that miR-
